{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,10]],"date-time":"2023-04-10T01:48:57Z","timestamp":1681091337491},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.cld.2015.04.002","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T15:59:06Z","timestamp":1436371146000},"page":"487-495","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Should We Treat Minimal\/Covert Hepatic Encephalopathy, and with What?"],"prefix":"10.1016","volume":"19","author":[{"given":"Phillip K.","family":"Henderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge L.","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2015.04.002_bib1","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.cgh.2012.05.026","article-title":"Covert hepatic encephalopathy: not as minimal as you might think","volume":"10","author":"Kappus","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2015.04.002_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cld.2011.12.006","article-title":"Management of covert hepatic encephalopathy","volume":"16","author":"Mullen","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2015.04.002_bib3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1155\/2013\/547670","article-title":"Minimal hepatic encephalopathy","volume":"27","author":"Stinton","year":"2013","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cld.2015.04.002_bib4","first-page":"3259","article-title":"Testing for minimal hepatic encephalopathy in the United States: an AASLD survey","volume":"52","author":"Bajaj","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.04.002_bib5","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1023\/A:1024784327783","article-title":"Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis","volume":"48","author":"Arguedas","year":"2003","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2015.04.002_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/hep.510280108","article-title":"Subclinical hepatic encephalopathy impairs daily functioning","volume":"28","author":"Groeneweg","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.04.002_bib7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.berh.2009.09.004","article-title":"Fall risk: the clinical relevance of falls and how to integrate fall risk with fracture risk","volume":"23","author":"Peeters","year":"2009","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.cld.2015.04.002_bib8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0168-8278(01)00026-5","article-title":"Neuropsychological characterization of hepatic encephalopathy","volume":"34","author":"Weisenborn","year":"2001","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2015.04.002_bib9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/ajg.2010.413","article-title":"Minimal hepatic encephalopathy is associated with falls","volume":"106","author":"Rom\u00e1n","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2015.04.002_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1011610427843","article-title":"Quality of life in cirrhotics with minimal hepatic encephalopathy","volume":"16","author":"Schomerus","year":"2001","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.cld.2015.04.002_bib11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/hep.20095","article-title":"Minimal hepatic encephalopathy impairs fitness to drive","volume":"39","author":"Wein","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.04.002_bib12","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1111\/j.1572-0241.2007.01424.x","article-title":"Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations","volume":"102","author":"Bajaj","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2015.04.002_bib13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/cpb.2008.0242","article-title":"Impairment of driving ability and neuropsychological function in patients with MHE disease","volume":"12","author":"Kim","year":"2009","journal-title":"Cyberpsychol Behav"},{"key":"10.1016\/j.cld.2015.04.002_bib14","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/hep.23128","article-title":"Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test","volume":"50","author":"Bajaj","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.04.002_bib15","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/ajg.2011.154","article-title":"Minimal hepatic encephalopathy and driving: is the genie out of the bottle","volume":"106","author":"Prakash","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2015.04.002_bib16","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1053\/j.gastro.2010.08.061","article-title":"Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy","volume":"140","author":"Bajaj","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2015.04.002_bib17","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1111\/j.1572-0241.2000.02265.x","article-title":"The prognostic significance of subclinical hepatic encephalopathy","volume":"95","author":"Hartman","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2015.04.002_bib18","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1053\/j.gastro.2010.02.015","article-title":"Persistence of cognitive impairment after resolution of overt hepatic encephalopathy","volume":"138","author":"Bajaj","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2015.04.002_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/lt.22197","article-title":"Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume","volume":"17","author":"Garcia-Martinez","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2015.04.002_bib20","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.clinthera.2013.07.421","article-title":"Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis","volume":"35","author":"Prakash","year":"2013","journal-title":"Clin Ther"},{"key":"10.1016\/j.cld.2015.04.002_bib21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1665-2681(19)31013-0","article-title":"Minimal hepatic encephalopathy. Should we treat it?","volume":"12","author":"Toapanta-Yanchapaxi","year":"2013","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cld.2015.04.002_bib22","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.20194","article-title":"Symbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis","volume":"39","author":"Liu","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.04.002_bib23","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1572-0241.2008.01861.x","article-title":"Probiotic yogurt for the treatment of minimal hepatic encephalopathy","volume":"103","author":"Bajaj","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2015.04.002_bib24","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cgh.2013.11.006","article-title":"Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial","volume":"12","author":"Lunia","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2015.04.002_bib25","first-page":"376A","article-title":"The role of probiotics in the treatment of minimal hepatic encephalopathy. A prospective, randomized placebo-controlled, double-blind study","volume":"60","author":"Vlachogiannakos","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.04.002_bib26","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1365-2036.2010.04574.x","article-title":"Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and xenobiotics on minimal hepatic encephalopathy","volume":"33","author":"Shukla","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2015.04.002_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/1319-3767.96443","article-title":"What improves minimal hepatic encephalopathy: probiotic yogurt, protein restriction or nonabsorbable disaccharides?","volume":"18","author":"Alfawaz","year":"2012","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.cld.2015.04.002_bib28","first-page":"180","article-title":"The diagnosis and treatment of minimal hepatic encephalopathy","volume":"109","author":"Zhan","year":"2012","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.cld.2015.04.002_bib29","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1023\/A:1005556826152","article-title":"Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy","volume":"45","author":"Dhiman","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2015.04.002_bib30","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/hep.21533","article-title":"Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy","volume":"45","author":"Prasad","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.04.002_bib31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4103\/1319-3767.96448","article-title":"Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction","volume":"18","author":"Sharma","year":"2012","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.cld.2015.04.002_bib32","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1080\/00365520600825117","article-title":"Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health related quality of life","volume":"41","author":"Kalaitzakis","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cld.2015.04.002_bib33","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/hep.25507","article-title":"Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis","volume":"55","author":"Bajaj","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.04.002_bib34","doi-asserted-by":"crossref","first-page":"e60042","DOI":"10.1371\/journal.pone.0060042","article-title":"Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy","volume":"8","author":"Bajaj","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cld.2015.04.002_bib35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ajg.2010.455","article-title":"Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial)","volume":"106","author":"Sidhu","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2015.04.002_bib36","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/hepr.12271","article-title":"Treatment for minimal hepatic encephalopathy: are we ghost busters","volume":"44","author":"Tomiya","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cld.2015.04.002_bib37","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/hepr.12235","article-title":"Oral l-ornithine-l-aspartate in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled trial","volume":"44","author":"Alvares-da-Silva","year":"2014","journal-title":"Hepatol Res"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326115000343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326115000343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T23:05:10Z","timestamp":1566947110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326115000343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1089326115000343"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2015.04.002","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should We Treat Minimal\/Covert Hepatic Encephalopathy, and with What?","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2015.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}